ArticleMolecular therapy : the journal of the American Society of Gene Therapy2024

Armored bicistronic CAR T cells with dominant-negative TGF-β receptor II to overcome resistance in glioblastoma.

Nannan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.